Market close: Surging F&P Healthcare drives sharemarket higher
The New Zealand sharemarket had a strong afternoon turnaround.
AdvertisementAdvertise with NZME.
Latest fromMarkets
The biggest market moments of 2021: From GameStop's revenge of the nerds to Tesla's trillion-dollar value
Financial Times: These events shaped a year of rapidly changing trading and investment.
Market close: Sharemarket falls to worst performance GFC
The New Zealand sharemarket has fallen 2.83 per cent this year.
Stock Takes: The best and worst moments on the market for 2021
The highlights and lowlights for 2021.
Market close: GDP data, US Fed tapering fails to sway investors
New Zealand sharemarket falls around half a per cent for the third successive day.
US Federal Reserve will cut back stimulus amid inflation concerns
Federal Reserve officials suggested three hikes in 2022.
Sharemarket continues to fight against rising interest rates
The New Zealand sharemarket had another down day, falling nearly half a per cent.
Jarden Brief: Auckland airport shares rise as city border opens
Jarden's daily update on the latest market moves and shakes.
Market close: Unpredictable sharemarket has another significant fall
On the plus side, retirement village operators are having a rebound.
Five-week freefall: Bitcoin's latest crash is 'deadly'
Bitcoin has hit a key milestone that has experts worried.
Market close: Property stocks back in favour
The New Zealand sharemarket posted a gain of more than one per cent.
Market close: Ebos surge takes it to new highs
The New Zealand sharemarket closed the week on a bright note.
Stock Takes: Interest rates, inflation loom large for 2022
Inflation and interest rates will be the key stock market investment themes in 2022.
Jarden Brief: Cryptocurrencies continue to stumble
Jarden's daily update on the latest market moves and shakes.
Market close: Investors take a breather as eyes turn to US inflation rate
The New Zealand sharemarket ended the day lower.
Market Watch: 'There have been a few landmines' - 2021 a year in review
A slower global recovery and high inflation have made 2021 a tough one for many investors.
Jarden Brief: Sky TV surge continues
Jarden's daily update on the latest market moves and shakes.
NZ shares follow sharp rise on Wall St as Omicron fears fade
The New Zealand sharemarket struck its biggest gain of the year.
Jarden Brief: Wall Street rallies on Omicron optimism
Jarden's daily update on the latest market moves and shakes.
Market close: Sky TV stands out in quiet day for sharemarket
Sky Network Television burst into life.
Market close: Vulcan steals limelight as sharemarket's woes continue
Uncertainty over Omicron and an out-of-favour utilities sector added to market's woes.
'I overreacted': The crypto exchange boss who hit back at Elon Musk
Elon Musk picked another fight online.
Market close: NZ shares rise to end the week
The New Zealand sharemarket is also taking a green light, red light approach lately.
What's the long-term side effects from Omicron on sharemarkets?
Will Omicron give share markets more than just the jitters?
Markets on edge as Omicron's shadow overhangs
The New Zealand sharemarket posted a fall of nearly half a per cent.
Market close: NZ shares hold steady after Wall St dive
The New Zealand sharemarket traded flat after a volatile three days.
Market close: NZ shares rebound for year's third biggest rise
Yesterday's sea of red on the main board turned to green.
Jarden Brief: Moderna CEO warns its vaccines will be less effective against Omicron
Jarden's daily update on the latest business news.
Sea of red: New Covid variant plays havoc with sharemarket
The NZ sharemarket recovered from an early morning deep dive, but still finished lower.
NZ sharemarket slides after investors shaken from Covid complacency
Investors have been shaken from their Covid-19 complacency by a new variant, Omicron.
Market close: Spooked sharemarket has biggest fall in eight months
Investors were spooked by a new Covid variant that has spread from Africa to Hong Kong.
Stock Takes: What now for F&P Healthcare after earnings dip?
What's next for F&P Healthcare now that Covid-19 looks to be in retreat?